Open | - |
Close | - |
Volume / Avg. | 0 / 327.383K |
Day Range | - - - |
52 Wk Range | 0.650 - 2.120 |
Market Cap | $126.279M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 0.23% |
Days to Cover | 1.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Rani Therapeutics Hldgs (NASDAQ:RANI), Alimera Sciences (NASDAQ:ALIM), Telomir Pharmaceuticals (NASDAQ:TELO), Trevi Therapeutics (NASDAQ:TRVI) and Cormedix (NASDAQ:CRMD).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by HC Wainwright & Co. on Thursday, March 14, 2024. The analyst firm set a price target for 6.00 expecting CLSD to rise to within 12 months (a possible 255.03% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $1.69 last updated March 18, 2024 at 5:25 PM EDT.
There are no upcoming dividends for Clearside Biomedical.
Clearside Biomedical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.